Ignacio García‐Tuñón

2.1k total citations
45 papers, 1.5k citations indexed

About

Ignacio García‐Tuñón is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ignacio García‐Tuñón has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Immunology. Recurrent topics in Ignacio García‐Tuñón's work include CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (6 papers) and Cell death mechanisms and regulation (5 papers). Ignacio García‐Tuñón is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), CAR-T cell therapy research (6 papers) and Cell death mechanisms and regulation (5 papers). Ignacio García‐Tuñón collaborates with scholars based in Spain, United States and Netherlands. Ignacio García‐Tuñón's co-authors include Mar Royuela, Mónica Ricote, Ricardo Paniagua, Benito Fraile, Alberto M. Pendás, Elena Llano, José Luís Barbero, Manuel Sánchez‐Martín, Fermín Rodríguez de Bethencourt and Antonio Ruíz and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Ignacio García‐Tuñón

45 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ignacio García‐Tuñón

Since Specialization

Citations

This map shows the geographic impact of Ignacio García‐Tuñón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio García‐Tuñón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio García‐Tuñón more than expected).

Fields of papers citing papers by Ignacio García‐Tuñón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio García‐Tuñón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio García‐Tuñón. The network helps show where Ignacio García‐Tuñón may publish in the future.

Co-authorship network of co-authors of Ignacio García‐Tuñón

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio García‐Tuñón. A scholar is included among the top collaborators of Ignacio García‐Tuñón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio García‐Tuñón. Ignacio García‐Tuñón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic Venous Disease during Pregnancy Is Related to Inflammation of the Umbilical Cord: Role of Allograft Inflammatory Factor 1 (AIF-1) and Interleukins 10 (IL-10), IL-12 and IL-18 2023 ·Journal of Personalized Medicine ·Lara Sánchez‐Trujillo, Óscar Fraile-Martínez, Cielo García‐Montero, (unknown), Luis G. Guijarro, Diego De León-Oliva, Diego Liviu Boaru, (unknown), M. Val Toledo-Lobo, Mar Royuela, Ignacio García‐Tuñón, (unknown), Juan A. De León-Luis, Coral Bravo, Melchor Álvarez‐Mon, Julia Buján, Miguel A. Sáez, Natalio Garcı́a-Honduvilla, Miguel Á. Ortega	6
2	Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease 2023 ·Genes ·Miguel Á. Ortega, Diego De León-Oliva, Cielo García‐Montero, Óscar Fraile-Martínez, Diego Liviu Boaru, M. Val Toledo-Lobo, Ignacio García‐Tuñón, Mar Royuela, Natalio Garcı́a-Honduvilla, Julia Buján, Luis G. Guijarro, Melchor Álvarez‐Mon, Miguel Ángel Álvarez-Mon	13
3	Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis 2022 ·Blood ·(unknown), Christian A. Di Buduo, (unknown), Vittorio Abbonante, (unknown), (unknown), (unknown), (unknown), (unknown), Pedro Ruiz‐Sala, María Jesús Peñarrubia, Emilia Pardal, Jesús María Hernández‐Rivas, José Ramón González‐Porras, Ignacio García‐Tuñón, Rocío Benito, José Rivera, Alessandra Balduini, José María Bastida	11
4	A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling 2022 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), (unknown), Ignacio García‐Tuñón, Rocío Benito, Verónica Palma‐Barqueros, Jesús María Hernández‐Rivas, José Ramón González‐Porras, José Rivera, José María Bastida	4
5	CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia 2021 ·The CRISPR Journal ·(unknown), José Luis Ordóñez, (unknown), Lucía Méndez, (unknown), (unknown), Julián Sevilla, Elena Sebastián, Sandra Muntión, Fermín Sánchez‐Guijo, Jesús María Hernández‐Rivas, Ignacio García‐Tuñón, Manuel Sánchez‐Martín	6
6	<i>Cyba</i>-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins 2020 ·Haematologica ·(unknown), (unknown), (unknown), Ignacio García‐Tuñón, Manuel Sánchez‐Martín, Ángel Hernández‐Hernández	6
7	CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition 2020 ·Leukemia ·Miguel Quijada‐Álamo, María Hernández‐Sánchez, (unknown), Ana E. Rodríguez‐Vicente, Ignacio García‐Tuñón, (unknown), Jesús María Hernández-Sánchez, Ana B. Herrero, José María Bastida, Laura San‐Segundo, Michaela Gruber, Juan Luis Garcı́a, Shanye Yin, Elisa ten Hacken, Rocío Benito, José Luis Ordóñez, Catherine J. Wu, Jesús María Hernández‐Rivas	25
8	C14ORF39/SIX6OS1 is a constituent of the synaptonemal complex and is essential for mouse fertility 2016 ·Nature Communications ·Laura Gómez-H, Natalia Felipe‐Medina, Manuel Sánchez‐Martín, Owen R. Davies, Isabel Ramos, Ignacio García‐Tuñón, Dirk G. de Rooij, Ihsan Dereli, Attila Tóth, José Luís Barbero, Ricardo Benavente, Elena Llano, Alberto M. Pendás	73
9	Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome 2015 ·PLoS ONE ·Sherezade Fuentes‐Julián, Francisco Arnalich‐Montiel, (unknown), (unknown), Alfonso Casado, Ignacio García‐Tuñón, Enrique Hernández-Jiménez, Eduardo López‐Collazo, María P. De Miguel	37
10	Mutant Cohesin in Premature Ovarian Failure 2014 ·New England Journal of Medicine ·Sandrine Caburet, Valerie A. Arboleda, Elena Llano, Paul A. Overbeek, José Luís Barbero, Kazuhiro Oka, Wilbur R. Harrison, Daniel Vaiman, Ziva Ben‐Neriah, Ignacio García‐Tuñón, Marc Fellous, Alberto M. Pendás, Reiner A. Veitia, Éric Vilain	196
11	A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism 2008 ·Cancer Research ·Silvestre Vicent, Diego Luis-Ravelo, Iker Antón, Ignacio García‐Tuñón, Francisco Borrás‐Cuesta, Javier Dotor, Javier De Las Rivas, Fernando Lecanda	81
12	Influence of IFN-gamma and its receptors in human breast cancer 2007 ·BMC Cancer ·Ignacio García‐Tuñón, Mónica Ricote, (unknown), Benito Fraile, Ricardo Paniagua, Mar Royuela	47
13	Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative) 2006 ·Cancer Science ·Ignacio García‐Tuñón, Mónica Ricote, Antonio Ruíz, Benito Fraile, Ricardo Paniagua, Mar Royuela	54
14	Cell Cycle Control Related Proteins (p53,p21, and Rb) and Transforming Growth Factorβ(TGFβ) in Benign and Carcinomatous (In Situ and Infiltrating) Human Breast: Implications in Malignant Transformations 2006 ·Cancer Investigation ·Ignacio García‐Tuñón, Mónica Ricote, Antonio Ruíz, Benito Fraile, Ricardo Paniagua, Mar Royuela	12
15	P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells 2006 ·APOPTOSIS ·Mónica Ricote, Ignacio García‐Tuñón, Benito Fraile, (unknown), Patricio Aller, Ricardo Paniagua, Mar Royuela	43
16	IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinoma 2005 ·Histopathology ·Ignacio García‐Tuñón, Mónica Ricote, Alejandro Borrego-Ruiz, Benito Fraile, Ricardo Paniagua, Mar Royuela	65
17	Potencial anti-apoptótico de p38 en cáncer de próstata 2005 ·Actas Urológicas Españolas ·(unknown), (unknown), Ignacio García‐Tuñón, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mar Royuela	4
18	The p38 transduction pathway in prostatic neoplasia 2005 ·The Journal of Pathology ·Mónica Ricote, Ignacio García‐Tuñón, Fermín Rodríguez de Bethencourt, Benito Fraile, (unknown), Ricardo Paniagua, Mar Royuela	76
19	Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma 2004 ·Cancer ·Mónica Ricote, Ignacio García‐Tuñón, Fermín Rodríguez de Bethencourt, Benito Fraile, Ricardo Paniagua, Mar Royuela	79
20	Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate 2003 ·The Journal of Pathology ·Mar Royuela, Mónica Ricote, (unknown), Ignacio García‐Tuñón, Ricardo Paniagua, María P. De Miguel	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact